Recon: Sarepta reports death of teen who received Duchenne gene therapy; Novartis to slash 427 jobs while revamping cardiovascular business
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.In Focus: US
- 8 key players inside RFK Jr.’s HHS (STAT)
- Walgreens Chair Pessina to boost stake after Sycamore seals takeover deal, FT reports (Reuters)
- FDA’s return-to-office chaos, probationary workers reinstated, and demotion fears (Focus) (Endpoints)
- Exclusive: Gates warns White House he can't fill shortfalls in US global health funding (Reuters)
- Teenager who received Elevidys, Sarepta’s Duchenne gene therapy, dies (STAT)
- Dr. Reddy’s, Sun Pharma and Zydus issue US recalls, citing failed specs and labeling issues (Fierce Pharma)
- WHO issues starkest warning yet on fallout from U.S. withdrawal of aid for global health (STAT)
- ‘No one can fill that gap’: Why a global health leader sees U.S. funding as irreplaceable (STAT)
- Big pharma fears best-selling drugs in crosshairs of US-EU tariff spat (Reuters)
- China encourages babymaking with free milk and childcare subsidies (Reuters)
- Eight countries could run out of HIV treatments due to USAID cuts, WHO says (Reuters)
- Saudi Arabia Expands Regulatory Role To Shape The Future Of Health And Longevity (MedTech Insight)
- CRISPR company Arbor Biotechnologies gets cash infusion from ARCH (STAT)
- Novartis to cut 400+ staffers in revamp of cardiovascular commercialization model (Endpoints)
- George Church spinout developing genomically recoded organisms cuts most employees (Endpoints)
- A Japanese biotech founded by Treg cell discoverer moves to the US with $45.8M (Endpoints)
- Sofinnova Partners lands €165M, backed by big pharma, to build early-stage biotechs in Europe (Endpoints)
- Mirador Pursues All Options To Be 2030’s Greatest I&I Breakthrough (BioSpace)
- Taiho Pharmaceutical Buys ADC Partner Araris for up to $1.1B Total (BioSpace)
- Klick buys Ward6 Singapore’s operations to fuel Asian expansion (Fierce Pharma)
- Merck plots 163 layoffs as it prepares to shutter Pennsylvania manufacturing site (Fierce Pharma)
- Google to Expand AI Answers to Medical Queries in Search Results (Bloomberg)
- 4 takeaways from AAOS 2025 (MedTech Dive)
- Nuralogix Launches ‘Next-Generation’ MagicMirror With 4G Connectivity (MedTech Insight)
- NHS England Abolition Fits UK Drive To Balance Regulation With Innovation (MedTech Insight)
- NIH cancels funding for landmark diabetes study at a time of focus on chronic disease (STAT)
- Eric Green is out as head of National Human Genome Research Institute (STAT)
- Private equity ‘gobbling’ up care facilities for people with disabilities (STAT)
- Banning direct-to-consumer drug ads won’t work (STAT)
- Congress created a unique plan to save rural hospitals — but few are using it (STAT)
- Q&A: How one advocacy group is stepping in to bolster transgender data (STAT)
- Top Insurance Chief to Head Back to School After Old Mutual Exit (Bloomberg)
A story’s inclusion in Regulatory Recon does not imply endorsement by Regulatory Focus or RAPS.
